| Identification | Back Directory | [Name]
1235995-16-0 | [CAS]
1235995-16-0 | [Synonyms]
1,3,4-Oxadiazol-2(3H)-one, 5-[(1R,3R)-1-(1-ethyl-1H-pyrazol-4-yl)-3-[5-(5-fluoro-2-pyridinyl)-1H-imidazol-2-yl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl]-3-methyl- | [Molecular Formula]
C27H24FN9O2 | [MOL File]
1235995-16-0.mol | [Molecular Weight]
525.54 |
| Hazard Information | Back Directory | [Uses]
MK-1421 is a potent and selective sstr3 antagonist. MK-1421 regulates insulin secretion by binding to the sstr3. MK-1421 can be used in the research of type 2 diabetes[1]. | [References]
[1] Shah S K, et al. Discovery of MK-1421, a potent, selective sstr3 antagonist, as a development candidate for type 2 diabetes[J]. ACS Medicinal Chemistry Letters, 2015, 6(5): 513-517. DOI:10.1021/ml500514w |
|
|